Nanometrics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.04.18	Nordic Nanovector Announces that Luigi Costa Will Step Down as Chief Executive Officer (PR Newswire)
04.04.18	Nordic Nanovector Announces that Luigi Costa Will Step Down as Chief Executive Officer (PR Newswire)
22.03.18	Global Oxygen Therapy Equipment Market 2012-2017 & 2022: Increasing Demand for Portable Oxygen Therapy Solutions & Gradual Transition Towards Oxygen Concentrators (PR Newswire)
15.03.18	Nordic Nanovector to Present Preclinical Data Highlighting the Anti-tumor Effect of Humalutin® in Three Lymphoma Models at AACR 2018 (PR Newswire)
15.03.18	Nordic Nanovector to Present Preclinical Data Highlighting the Anti-tumor Effect of Humalutin® in Three Lymphoma Models at AACR 2018 (PR Newswire)
12.03.18	Nordic Nanovector to Present at the China Healthcare Investing and Partnering Symposium in China and Stifel Nordic Healthcare Seminar in London (PR Newswire)
12.03.18	Nordic Nanovector to Present at the China Healthcare Investing and Partnering Symposium in China and Stifel Nordic Healthcare Seminar in London (PR Newswire)
27.02.18	Nordic Nanovector ASA - Results for the Fourth Quarter and Full Year 2017: Solid Performance Through 2017, Moving Forward With Pivotal Trial (PR Newswire)
27.02.18	Nordic Nanovector ASA - Results for the Fourth Quarter and Full Year 2017: Solid Performance Through 2017, Moving Forward With Pivotal Trial (PR Newswire)
20.02.18	Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation and Webcast (PR Newswire)
20.02.18	Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation and Webcast (PR Newswire)
16.02.18	Solteq Plc: Correction to the Notice to the Annual General Meeting of Shareholders March 27, 2018 (PR Newswire)
05.02.18	Nordic Nanovector ASA - Allocation of PSUs (PR Newswire)
05.02.18	Nordic Nanovector ASA - Allocation of PSUs (PR Newswire)
01.02.18	Nordic Nanovector Appoints Malene Brondberg as Vice President, Investor Relations and Corporate Communications (PR Newswire)
01.02.18	Nordic Nanovector Appoints Malene Brondberg as Vice President, Investor Relations and Corporate Communications (PR Newswire)
29.01.18	Nordic Nanovector ASA - Allocation of PSUs (PR Newswire)
29.01.18	Nordic Nanovector ASA - Allocation of PSUs (PR Newswire)
18.01.18	AI Innovations That will Transform the Future of Manufacturing: 2017 Research Report (PR Newswire)
18.01.18	AI Innovations That will Transform the Future of Manufacturing: 2017 Research Report (PR Newswire)
26.12.17	FDA Oks Nanobiotix's First Immuno-Oncology Trial (RTTNews)
22.12.17	MediSapiens Joins the FinnGen Project and Brings Solutions to Curation, Management and Visualization of Genetic and Clinical Data of 500.000 Finns (PR Newswire)
20.12.17	Nordic Nanovector ASA - Extraordinary General Meeting Held (PR Newswire)
20.12.17	Nordic Nanovector ASA - Extraordinary General Meeting Held (PR Newswire)
12.12.17	Nordic Nanovector to Present at DNB Nordic Healthcare Conference (PR Newswire)
12.12.17	Nordic Nanovector to Present at DNB Nordic Healthcare Conference (PR Newswire)
12.12.17	2017 "TV Landmark" research results issued, GHS president Jason Kong was honored "Man of the Year" (PR Newswire)
11.12.17	Betalutin® Shows Strong Clinical Profile in Relapsed/refractory Indolent NHL and Follicular Lymphoma (PR Newswire)
11.12.17	Betalutin® Shows Strong Clinical Profile in Relapsed/refractory Indolent NHL and Follicular Lymphoma (PR Newswire)
08.12.17	Nordic Nanovector: Invitation to Conference Call for Updated Results From the LYMRIT 37-01 Phase 1/2 Trial, to be Presented at ASH (PR Newswire)
08.12.17	Nordic Nanovector: Invitation to Conference Call for Updated Results From the LYMRIT 37-01 Phase 1/2 Trial, to be Presented at ASH (PR Newswire)
04.12.17	Nordic Nanovector to Present at Carnegie Nordic Healthcare Day (PR Newswire)
04.12.17	Nordic Nanovector to Present at Carnegie Nordic Healthcare Day (PR Newswire)
29.11.17	Nordic Nanovector: Notice of Extraordinary General Meeting (PR Newswire)
29.11.17	Nordic Nanovector: Notice of Extraordinary General Meeting (PR Newswire)
22.11.17	Nordic Nanovector Capital Markets Day 2017 (PR Newswire)
22.11.17	Nordic Nanovector Capital Markets Day 2017 (PR Newswire)
22.11.17	Nordic Nanovector ASA - Results for the Third Quarter 2017 (PR Newswire)
22.11.17	Nordic Nanovector ASA - Results for the Third Quarter 2017 (PR Newswire)
15.11.17	Nordic Nanovector ASA - Financial Calendar (PR Newswire)
15.11.17	Nordic Nanovector ASA - Financial Calendar (PR Newswire)
13.11.17	Nordic Nanovector to Present at Jefferies Global Healthcare Conference (PR Newswire)
13.11.17	Nordic Nanovector to Present at Jefferies Global Healthcare Conference (PR Newswire)
08.11.17	Nordic Nanovector: Protocol Amendment Filed in the UK to Enable Initiation of Phase 2 PARADIGME (PR Newswire)
08.11.17	Nordic Nanovector: Protocol Amendment filed in the UK to enable initiation of Phase 2 PARADIGME (PR Newswire)
07.11.17	Nordic Nanovector ASA (OSE: NANO) to Host Capital Markets Day and Present Q3 Results on 22 November 2017 in Oslo (PR Newswire)
07.11.17	Nordic Nanovector ASA (OSE: NANO) to Host Capital Markets Day and Present Q3 Results on 22 November 2017 in Oslo (PR Newswire)
01.11.17	Nordic Nanovector: Updated Results From Phase 1/2 Trial of Betalutin® in Non-Hodgkin Lymphoma to be Presented at ASH in December (PR Newswire)
01.11.17	Nordic Nanovector: Updated Results From Phase 1/2 Trial of Betalutin® in Non-Hodgkin Lymphoma to be Presented at ASH in December (PR Newswire)
23.10.17	Nordic Nanovector: Presentations at European Association of Nuclear Medicine Annual Meeting (EANM) (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

29.11.24		Freitagshandel in New York: NASDAQ 100 zeigt sich zum Handelsende fester
29.11.24		Pluszeichen in New York: NASDAQ 100 in der Gewinnzone
29.11.24		Handel in New York: S&P 500 präsentiert sich am Freitagmittag fester
29.11.24		NASDAQ 100 aktuell: NASDAQ 100-Börsianer greifen am Freitagmittag zu
29.11.24		NASDAQ 100-Handel aktuell: NASDAQ 100 zum Handelsstart mit Zuschlägen
29.11.24		Börse New York: S&P 500 steigt zum Handelsstart
13.11.24		NASDAQ 100 aktuell: NASDAQ 100 am Nachmittag mit Kursplus
13.11.24		Handel in New York: NASDAQ 100 verbucht Verluste

29.11.24

Freitagshandel in New York: NASDAQ 100 zeigt sich zum Handelsende fester

29.11.24

Pluszeichen in New York: NASDAQ 100 in der Gewinnzone

29.11.24

Handel in New York: S&P 500 präsentiert sich am Freitagmittag fester

29.11.24

NASDAQ 100 aktuell: NASDAQ 100-Börsianer greifen am Freitagmittag zu

29.11.24

NASDAQ 100-Handel aktuell: NASDAQ 100 zum Handelsstart mit Zuschlägen

29.11.24

Börse New York: S&P 500 steigt zum Handelsstart

13.11.24

NASDAQ 100 aktuell: NASDAQ 100 am Nachmittag mit Kursplus

13.11.24

Handel in New York: NASDAQ 100 verbucht Verluste

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	73.72	1.96 %	K V
ABB	51.94	1.33 %	K V
CieFinRichemont	128.90	0.98 %	K V
Alcon	77.76	0.83 %	K V
Geberit	548.80	0.59 %	K V
Zurich Insur Gr	557.20	-0.64 %	K V
Swiss Life Hldg	684.20	-0.90 %	K V
Holcim	91.02	-0.91 %	K V
Kuehne+Nagel Int	210.30	-1.45 %	K V
Novartis	90.14	-3.10 %	K V

Nachrichten zu Nanometrics Inc.

Aktien Top/Flop

Nanometrics Peer Group Nachrichten

Meistgelesene Nachrichten